[Adjuvant and neoadjuvant systemic therapy of breast carcinoma]

Internist (Berl). 2002 Mar;43(3):341-4, 347-53. doi: 10.1007/s00108-001-0523-3.

[Article in German]

Authors

P Schmid¹, K Possinger

Affiliation

¹ Medizinische Klinik mit Schwerpunk Onkologie und Hämatologie, Charité Campus Mitte, Humboldt-Universität, Schumannstr. 20/21, 10117 Berlin. peter.schmid@charite.de

PMID: 11963719
DOI: 10.1007/s00108-001-0523-3

No abstract available

Publication types

Review

MeSH terms

Breast Neoplasms / mortality
Breast Neoplasms / pathology
Breast Neoplasms / therapy*
Chemotherapy, Adjuvant
Combined Modality Therapy
Female
Humans
Lymphatic Metastasis
Neoadjuvant Therapy*
Neoplasm Staging
Prognosis
Survival Rate